Evidence map›Paper›PMID 25206003›Full record

ArticleAnnals of neurosciences2013

Withania somnifera root extract extends lifespan of Caenorhabditis elegans.

Ranjeet Kumar, Kuldeep Gupta, Kopal Saharia, Deepak Pradhan, Jamuna R Subramaniam

Open access · greenAbstract read
In one paragraph

Article in Annals of neurosciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Safety and tolerability of Ashwagandha (Frontiers in nutrition · 2026
    Trial
  3. Review
  4. Review
  5. Emerging Vistas for the NutraceuticalPharmaceuticals (Basel, Switzerland) · 2024
    Review
  6. The Protective Activity ofInternational journal of nephrology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Drug target insights
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ranjeet KumarDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, INDIA.
Kuldeep GuptaDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, INDIA.
Kopal SahariaDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, INDIA.
Deepak PradhanIXOREAL Biomed Pvt. Ltd., Hyderabad, INDIA.
Jamuna R SubramaniamDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, INDIA.
Indian Institute of Technology Kanpur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the ancient Indian herbal medicine system several ayurvedic preparations are claimed to have longevity enhancing effects. But, so far, no clear scientific evidence has been provided. One among them, is the roots of the plant, commonly known as Ashwagandha (Withania somnifera Dunal- WSD), which is supposed to have myriad of beneficial effects including long life. PURPOSE: Here, we evaluated both the root extract (RE) and its purified ingredients (PI-RE) with a similar composition as in RE obtained from the roots of WSD for lifespan extension in the well established model system, C. elegans. PI-RE could extend the lifespan of C. elegans.

methodsWe used wild type C. elegans (N2) or RB918: acr-16 (ok789); andNL2099: rrf-3 (pk1426) mutant worms and analysed their lifespan assay in Ashwagandha extract spreaded on plates containing Bacterial Lawns.

resultsStrangely, while there was no effect on the wild type worms, the mutant for the human nicotinic acetylcholine receptor, nAchR, α7 equivalent, acr-16, showed around ~20% lifespan extension when treated with PI-RE.

conclusionThus, we are able to show that one of the age old healthy longlife supplements, Ashwagandha does extend lifespan of C. elegans.

Indexed as

AshwagandhaC. elegansLifespan extensionWithanolides

Identifiers

PMID25206003
PMCPMC4117092
OpenAlexW2110843300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.